We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,231
Increased
3,688
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFX icon
6151
PhenixFIN
PFX
$90M
$98.8K ﹤0.01%
2,113
-3
-0.1% -$135
SRTS icon
6152
Sensus Healthcare
SRTS
$50.5M
$98.8K ﹤0.01%
+18,538
New +$85.2K
ZYXI
6153
DELISTED
Zynex
ZYXI
$98.8K ﹤0.01%
10,598
-7,378
-41% -$78.5K
BTOG icon
6154
Bit Origin
BTOG
$2.21M
$98.4K ﹤0.01%
570
+544
+2,092% +$123K
NRO
6155
Neuberger Real Estate Securities Income Fund Inc
NRO
$190M
$98.4K ﹤0.01%
30,634
-1,349
-4% -$4.16K
FDVV icon
6156
Fidelity High Dividend ETF
FDVV
$10.4B
$98.2K ﹤0.01%
+2,100
New +$96K
PEZ icon
6157
Invesco Dorsey Wright Consumer Cyclicals Momentum ETF
PEZ
$22.9M
$98K ﹤0.01%
1,022
-253
-20% -$23.7K
XPEL icon
6158
XPEL
XPEL
$1.38B
$97.9K ﹤0.01%
2,754
-10,961
-80% -$472K
ILPT
6159
Industrial Logistics Properties Trust
ILPT
$586M
$97.7K ﹤0.01%
26,539
+14,878
+128% +$57.5K
VXZ icon
6160
iPath Series B S&P 500 VIX Mid-Term Futures ETN
VXZ
$30.7M
$97.6K ﹤0.01%
1,963
+399
+26% +$20.6K
IJUL icon
6161
Innovator International Developed Power Buffer ETF July
IJUL
$254M
$97.2K ﹤0.01%
3,458
+3,331
+2,623% +$93.7K
FSBW icon
6162
FS Bancorp
FSBW
$320M
$97.2K ﹤0.01%
2,667
-4,315
-62% -$141K
GMAY icon
6163
FT Vest US Equity Moderate Buffer ETF May
GMAY
$540M
$97.1K ﹤0.01%
2,776
-12,177
-81% -$418K
VEEV icon
6164
PUT
Veeva Systems
VEEV
$37.4B
$97K ﹤0.01%
+530
New +$105K
AFYA icon
6165
Afya
AFYA
$1.27B
$96.9K ﹤0.01%
5,490
+4,259
+346% +$74.2K
HYSA icon
6166
BondBloxx USD High Yield Bond Sector Rotation ETF
HYSA
$65.4M
$96.7K ﹤0.01%
6,519
+6,395
+5,157% +$94.7K
ONEW icon
6167
OneWater Marine
ONEW
$201M
$96.6K ﹤0.01%
3,505
-8,336
-70% -$215K
ADIL
6168
Adial Pharmaceuticals
ADIL
$8.71M
$96.1K ﹤0.01%
3,344
+3,115
+1,360% +$118K
CLCO
6169
DELISTED
Cool Company
CLCO
$95.9K ﹤0.01%
8,152
-3,362
-29% -$38.7K
PSCU icon
6170
Invesco S&P SmallCap Utilities & Communication Services ETF
PSCU
$17.6M
$95.8K ﹤0.01%
1,913
-556
-23% -$28.1K
ME
6171
DELISTED
23andMe Holding Co
ME
$95.8K ﹤0.01%
12,245
-10,691
-47% -$102K
NCDL icon
6172
Nuveen Churchill Direct Lending
NCDL
$633M
$95.7K ﹤0.01%
5,500
-21,972
-80% -$387K
USIO icon
6173
Usio Inc
USIO
$64M
$95.7K ﹤0.01%
62,535
+59,636
+2,057% +$92K
HSAI
6174
Hesai Group
HSAI
$3.02B
$95.7K ﹤0.01%
22,831
+21,716
+1,948% +$103K
HSY icon
6175
PUT
Hershey
HSY
$36.6B
$95.6K ﹤0.01%
+520
New +$101K

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.